Effects of fullerene [C.sub.60] nanocomposites on human platelet aggregation

The effects of fullerene [C.sub.60] nanocomposites on human platelet aggregation induced by ADP, ristocetin, and collagen were studied. The nanocomposite containing fullerene [C.sub.60] in polyvinyl pyrrolidone solution did not change platelet aggregation, while fullerene [C.sub.60] in crown ether a...

Full description

Saved in:
Bibliographic Details
Published inBulletin of experimental biology and medicine Vol. 152; no. 5; p. 624
Main Authors Vaschenko, V.I, Samonin, V.V, Popov, V.A, Antonenkova, E.V, Nikonova, V.J, Vilyaninov, V.N, Podvjaznikov, M.L, Kidalov, V.N, Titulova, T.B, Vaschenko, T.N
Format Journal Article
LanguageEnglish
Published Springer 01.03.2012
Subjects
Collagen
Crown ethers
Nanotechnology
Online AccessGet full text

Cover

More Information
Summary:The effects of fullerene [C.sub.60] nanocomposites on human platelet aggregation induced by ADP, ristocetin, and collagen were studied. The nanocomposite containing fullerene [C.sub.60] in polyvinyl pyrrolidone solution did not change platelet aggregation, while fullerene [C.sub.60] in crown ether and Twin-80 solutions inhibited ADP-induced platelet aggregation by 20 and 30%, respectively. Key Words: fullerene [C.sub.60]; platelet aggregation; polyvinyl pyrrolidone; crown ethers; Twin-80
ISSN:0007-4888
1573-8221